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Abstract 23 
Intrauterine infusion of peanut oil at Day 10 post-ovulation has been reported to prolong 24 
dioestrus in mares. However, the effects of peanut oil treatment on the endometrium and 25 
whether the technique is painful have not been assessed. The objectives of this study were, (i) 26 
to determine the effect of intrauterine infusion of peanut oil on endometrial health, (ii) to 27 
determine whether use of intrauterine peanut oil is painful and (iii) to confirm that peanut oil 28 
causes prolonged dioestrus. Six mares aged 3-12 years old were used in a cross-over design 29 
with each mare administered both 1 ml of intrauterine peanut oil and a sham treatment on 30 
different oestrous cycles. The effect of intrauterine infusion of 1 ml peanut oil or sham 31 
treatment were measured using interovulatory period, uterine fluid accumulation as 32 
determined by transrectal ultrasonography, serum progesterone levels, endometrial Kenney 33 
biopsy scores and histological features, endometrial eosinophil numbers and salivary cortisol 34 
measurements. The individual mare response to intrauterine infusion of peanut oil was 35 
variable. Peanut oil infusion did not statistically prolong the luteal phase, nor elevate salivary 36 
cortisol levels but did cause superficial erosion of the endometrial surface epithelium in all 37 
mares and significantly increased eosinophil numbers in the endometrium (P=0.0068). The 38 
Kenney grade for biopsies from 2/6 mares worsened transiently following infusion. In 39 
conclusion, intra-uterine peanut oil does not statistically increase the duration of the luteal 40 
phase but results in an inflammatory response and increase in endometrial eosinophil 41 
numbers suggesting treatment may be associated with a hypersensitivity-type reaction. Those 42 
contemplating using peanut oil to suppress oestrus should also be aware of the legislative and 43 
regulatory implications.  44 
 45 
 46 
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Introduction 47 
Oestrus-related behavioural issues in mares can disrupt athletic performance [1-6]. 48 
Altrenogest (Regumate Equine1) is probably the drug most commonly used to suppress 49 
oestrus in mares. Internationally, its use in mares is not allowed by some governing bodies 50 
(e.g. the British Horseracing Authority [7]), but is allowed by others (e.g. the FEI, under 51 
certification, [8]; New South Wales Racing [9], and the Hurlingham Polo Association [10]). 52 
However, the use of Regumate Equine1 is not unproblematic since it has the potential to 53 
cause positive drug test results for in-contact horses via feed contamination [11], and poses 54 
risks to pregnant women, women of childbearing age, and those with certain types of tumour 55 
and thrombo-embolic disease. Furthermore, it requires daily administration, which can be 56 
burdensome to some commercial operations.   57 
 58 
Injectable Altrenogest may provide reliable, short-term suppression of the behavioural signs 59 
of oestrus, and avoid some of the problems associated with handling the oral product [6, 12]. 60 
Such a product (Readyserv2) is currently licensed in Australia. The use of 61 
medroxyprogesterone acetate (MPA) has been shown to be ineffective in suppressing oestrus 62 
in mares [3, 12, 13]. Repeated injections with low dose intravenous [14] or high dose 63 
intramuscular [15] oxytocin prolongs dioestrus (thereby suppressing oestrus) in up to 70% of 64 
mares. However, protocols require daily injections for 7-29 days [14, 15] which is 65 
challenging for some owners, with some additionally considering the protocol a welfare 66 
concern. Injection of human Chorionic Gonadotrophin during dioestrus also potentially 67 
prolongs dioestrus, but has only been assessed in a small number of mares [16]. 68 
Gonadotrophin releasing hormone (GnRH) vaccines (reviewed in [4]) can be effective in 69 
suppressing oestrus [5, 17]. However, there is individual variation in response to treatment 70 
with some (particularly older mares) requiring repeated vaccinations, and other mares 71 
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entering prolonged (> 12 months) suppression of reproductive cyclicity [4, 17]. This may be 72 
undesirable in a commercial context, particularly if the owner wishes to breed the mare 73 
immediately following retirement from competition. 74 
 75 
Reports of non-medicinal methods of oestrus suppression include the insertion of a marble 76 
into the mare’s uterus [18-20], manual disruption of an early embryo (to induce pseudo-77 
pregnancy) [2]; and, anecdotally, covert ovariectomy. Intrauterine marbles suppress oestrus 78 
unreliably [19, 20] have been reported to fracture [21], to be associated with colic [22] and 79 
can damage the endometrium, impacting upon future fertility. There are also ethical issues 80 
associated with failure to declare the insertion of an intrauterine marble, during competition, 81 
or at sale. Establishing pregnancies in order to kill the embryos is unlikely to be viewed by 82 
the general public as ethically acceptable practice [2]. Ovariectomy not only renders the mare 83 
irreversibly infertile, but also surgical risks which may be difficult to justify in an ethical 84 
harm:benefit analysis, particularly since ovariectomy does not always abolish oestrus 85 
behaviour [23].   86 
 87 
In 2011, intrauterine infusion of fractionated coconut oil or peanut oil at Day 10 post-88 
ovulation was reported to cause prolonged dioestrus in mares [24]. Potentially, this method of 89 
oestrus suppression has the advantages of not requiring medical treatment at the time of 90 
competition; of being non-painful; of not carrying drug-associated risks to in-contact humans 91 
or horses, and not causing long-term disruption to the reproductive cycle.  92 
 93 
Peanut oil is a more probable candidate for oestrus suppression via prostaglandin synthesis 94 
regulation than coconut oil, since peanut oil is comprised of mono- and poly-unsaturated fatty 95 
acids (PUFAs) [25], whereas coconut oil is comprised primarily of saturated fatty acids [26].  96 
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Notably, the second most abundant fatty acid in peanut oil is omega-6 PUFA, linoleic acid, 97 
which has been shown to modulate prostaglandin synthesis and influence the relative 98 
production of PGF and PGE in ruminant endometrial cells. If these observations in ruminants 99 
are applied to mare endometrial cells, it is possible that exposure of equine endometrial cells 100 
to linoleic acid could decrease the synthesis of PGF and subsequently inhibit luteolysis [27].  101 
Anecdotally, peanut oil is being used in clinical practice as a method of oestrus suppression 102 
in mares, following the publication of the paper of Wilsher and Allen in 2011[24]. However, 103 
a 2016 paper [28] showed that intrauterine coconut oil causes an inflammatory reaction in the 104 
endometrium, which raises the possibility that treatment with intrauterine plant oil can have a 105 
detrimental effect on endometrial health and subsequently future fertility. Furthermore, no 106 
studies have been reported assessing whether the intrauterine infusion of either coconut or 107 
peanut oil is painful for mares. This paper therefore aimed to investigate the clinical 108 
suitability of intrauterine administration of peanut oil as a reversible, welfare-friendly and 109 
ethical method of oestrus suppression in mares. The objectives of the study were (i) to 110 
determine the effect of intrauterine infusion of peanut oil on endometrial health, (ii) to 111 
determine whether use of intrauterine peanut oil is painful and (iii) to confirm that peanut oil 112 
causes prolonged dioestrus. 113 
 114 
 115 
2. Materials and Methods 116 
2.1 Mares 117 
All animal work was performed in accordance with the Animals (Scientific Procedures) Act 118 
1986 guidelines set by the Home Office and Ethics Committee of the Royal Veterinary 119 
College (PPL 70/8577). Six mares were identified as being suitable for inclusion in the study 120 
following a clinical reproductive examination, and grading of a screening uterine biopsy 121 
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sample as Kenney Grade I or IIa. The mares were aged between 3 and 14 years old. Two 122 
were Dartmoor ponies (history of donation of multiple embryos); one Standardbred type (no 123 
history of foaling); two warmbloods (one maiden, one pluriparous) and one Morgan (who had 124 
donated multiple embryos and foaled herself once). The study took place in the physiological 125 
breeding seasons across two consecutive years. All mares were kept at grass. Before the start 126 
of the experiment, mares were accustomed for 4 days to entering the examination stocks for 127 
up to 15 minutes, to rectal examination, and to having saliva swabs taken (see below), in 128 
order to minimise/ eliminate the potentially confounding stress which those procedures might 129 
cause.  130 
 131 
2.2 Study design  132 
All six mares were used according to a cross-over design. For the cortisol and efficacy 133 
studies, randomisation of treatment order was included with 3 mares receiving a sham 134 
treatment at oestrous one and oil treatment in oestrous two and a further 3 mares receiving oil 135 
treatment in oestrous one and sham treatment in oestrous two. For the assessment of 136 
endometrial health, all six mares had control biopsies collected at the oestrus prior to both the 137 
oestrous periods referenced above. Randomisation for this part of the study was not possible 138 
as pre-oil samples were required as controls.  139 
 140 
Following initial induction of oestrus by intramuscular injection of 125-250 mcg cloprostenol 141 
(Estrumate3), each mare had pre-treatment endometrial biopsy samples taken during oestrus  142 
(see below for biopsy methods). No further treatments were carried out in the oestrus period 143 
in which the pre-treatment endometrial biopsy samples were collected. Having acquired these 144 
baseline, pre-treatment endometrial biopsy samples, experiments were undertaken across two 145 
subsequent oestrus periods according to the cross over design above.  146 
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 147 
2.3 Monitoring and manipulation of the reproductive tract 148 
Reproductive status including return to oestrus, ovulation and evaluation of the uterus was 149 
monitored by a combination of rectal examination, transrectal ultrasonographic evaluation of 150 
the reproductive tract, and biweekly serum progesterone sampling (see below). Biweekly 151 
serum progesterone continued throughout the initial post-treatment return to oestrus, 152 
subsequent dioestrus, and until subsequent return to oestrus had been demonstrated, up to a 153 
maximum of 60 days. Ten days after ovulation, mares received either an intrauterine ‘sham’ 154 
treatment or peanut oil treatment according to the cross over design (n=3 received sham 155 
treatment at this first cycle later followed by oil treatment at a subsequent cycle and n=3 156 
received an oil treatment at this first cycle, later to have a sham treatment at a subsequent 157 
cycle). The mare was placed in stocks, her rectum manually evacuated, her tail wrapped in a 158 
clean rectal glove and bandaged, and her vulva and perineum washed with dilute 159 
chlorhexidine gluconate solution (Hibiscrub4) until scrupulously clean, rinsed with water, and 160 
dried. An AI pipette was introduced through the mare’s dioestrus cervix using a conventional 161 
sterile embryo transfer technique [29] taking care not to digitally penetrate the cervical canal, 162 
and to minimise trauma to it.  The peanut oil was infused as follows: 3.0 ml Peanut oil 163 
(Arachis Oil BP200895, Table I) taken from a 5 ml aliquot which had been sterilised using a 164 
Millex-GP Syringe 0.22 µm Filter Unit106, was loaded by aspiration into a sterile AI pipette 165 
with a syringe attached. One ml of oil was deposited into the uterine body.  The fact that the 166 
oil had been loaded by aspiration into the distal end of the pipette ensured that the full 1ml 167 
was deposited. The catheter was not flushed, due to the potentially confounding, 168 
inflammatory effects on the uterus of air or flushing liquids.  The catheter was withdrawn, 169 
and the uterus massaged per rectum to ensure that the oil was distributed throughout the 170 
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uterus. As a control (sham), the same procedure was performed but no oil (or any other fluid) 171 
deposited into the uterine body.   172 
 173 
When mares received a sham treatment, they were monitored until 240 minutes post-174 
treatment for any behavioural signs of discomfort, or vulval discharge.  During this time 175 
mares were kept in a familiar stall or paddock, with their normal companion. Saliva samples 176 
were collected to measure salivary cortisol (see below).  177 
 178 
When mares received intrauterine peanut oil, they were monitored until 240 minutes post-179 
treatment for any behavioural signs of discomfort, or vulval discharge. Saliva samples were 180 
collected to measure salivary cortisol (see below). Twenty-four hours post treatment, the 181 
mare’s reproductive tract was examined by rectal palpation and ultrasonography. The 182 
ultrasonographic appearance of the corpus luteum and the uterus, and the depth and 183 
echogenicity [30] of any free intrauterine fluid were assessed and recorded, as was the 184 
presence of any vulval discharge. These examinations were performed for 3-5 days or until 185 
no abnormalities were recorded. 186 
 187 
When progesterone values fell to 0-1 ng/ml following the oil treatment, suggesting a return to 188 
oestrus, this was confirmed by palpation and ultrasound imaging of the reproductive tract. 189 
Endometrial biopsies were taken at the first oestrus immediately following oil infusion 190 
according to the criteria and technique described above. This time point was chosen for post-191 
treatment biopsies as it reflected when mares might be assessed for future breeding use 192 
following intrauterine treatment in a clinical setting. Additionally, to check for infection, in 193 
addition to endometrial biopsies endometrial swabs were taken (using a guarded technique) at 194 
this oestrus in three mares that had free fluid in the uterus 24 hours following administration 195 
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of the oil. (Swabbing was only performed in mares with significant ultrasonographically 196 
visible free fluid in the uterus, because swabbing in the absence of clinical suggestion of 197 
endometritis was not written into the experimental licensing protocol). If the Kenney grade 198 
attributed to the post-treatment biopsy sample was the same or better than the pre-treatment 199 
result from the same site in the same mare, no further biopsies were taken. Where the Kenney 200 
grade for the post-treatment sample was worse than that of the pre-treatment sample, further 201 
biopsies were taken at the next oestrus period (2/6 mares). 202 
 203 
2.4 Endometrial biopsies 204 
Pre-treatment (control) and post-oil treatment endometrial biopsies were taken from each 205 
mare as follows. Reproductive status was monitored using rectal palpation, ultrasound 206 
imaging of the reproductive tract, and progesterone assay, as described above. Pre-treatment 207 
and post-treatment endometrial biopsies were taken from each mare in oestrus, i.e. when she 208 
had at least one ovarian follicle of ≥35mm diameter; significant uterine oedema, and a 209 
relaxed cervix, and recorded serum progesterone levels were 0-1ng/ml.  One biopsy was 210 
taken from the base of each uterine horn using Equivet endometrial biopsy forceps (Kruuse 211 
UK6), and conventional biopsying technique [31] under light sedation (40 µg/kg i.v. 212 
Romifidine, (Sedivet 1% Injection7). Endometrial biopsies were individually preserved in 213 
10% buffered formalin. Each sample was attributed a random code for labelling.  The date, 214 
identity of the mare, sample site (right or left horn), and code were recorded by the person 215 
taking the biopsies. All endometrial biopsies were submitted to the Royal Veterinary College 216 
Diagnostic Laboratory, processed to paraffin wax and sectioned at 6 µm using standard 217 
techniques, then examined and graded using the Kenney and Doig system (1986) by a 218 
specialist veterinary pathologist (KCS), who was blinded to the identity of the mare and the 219 
stage of treatment. Eosinophil counts were performed by counting the absolute number of 220 
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eosinophils in ten randomly selected sections of endometrium examined at x400 221 
magnification. 222 
 223 
2.5 Saliva sampling and Cortisol Assay  224 
An initial, baseline saliva sample (‘Paddock’) was taken from the mare at rest (i.e. in a 225 
familiar paddock or stable, in familiar company) by holding a Salivette8 swab between locked 226 
forceps and gently rolling the swab around the mare’s tongue and between her tongue and 227 
cheeks for approximately one minute. The Salivette was returned to ice for ≤ 4 hours before 228 
transportation to the laboratory. Mares were brought into the breeding barn in the company of 229 
a familiar companion, to minimise stress. The mare was then placed in stocks, her rectum 230 
manually evacuated, her tail wrapped in a clean rectal glove and bandaged, and her vulva and 231 
perineum washed with dilute chlorhexidine gluconate solution (Hibiscrub4) until scrupulously 232 
clean, rinsed with water, and dried. With the mare in stocks, a second saliva swab was taken 233 
(‘pre-treatment’). The mare was then treated either with sham infusion, or with infusion of 234 
peanut oil as above. Additional saliva swabs were taken at 10, 30, 45, 60, 90, 120, 180 and 235 
240 minutes post sham/oil treatment, when the mares was in her familiar stable or paddock, 236 
with her familiar companion.  237 
 238 
Additionally, three mares underwent a further study of cortisol reactions to being placed in 239 
stocks, as follows. Mares had a baseline saliva sample taken at rest. They were then led into 240 
the stocks and had a second swab taken whilst in the stocks (in the absence of a rectal 241 
examination), 15 minutes after the first sample was taken. The mares were removed from the 242 
stocks and had further swabs taken at 45, 75, 195 and 255 minutes after the first sample.  243 
 244 
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Salivette swabs inside their collection tubes were stored on ice until transported to the 245 
laboratory. Tubes were then centrifuged for 10 minutes at 1000xg. Recovered saliva was 246 
transferred to a 1.5 mL centrifuge tube and stored at -20°C until analysis. All saliva samples 247 
were frozen within 4 hours of collection. Salivary cortisol analysis was carried out using an 248 
enzyme immunoassay based on a competitive format (Salimetrics, State College, PA) as 249 
described by the manufacturer. Briefly, saliva samples were thawed, vortexed, and 250 
centrifuged at 1500xg to precipitate mucins. Samples and cortisol-HRP conjugate were added 251 
to a microtiter plate pre-coated with monoclonal anti-cortisol antibodies. The plate was 252 
incubated for 1 hour at room temperature. Each well was washed 4 times with phosphate-253 
based wash buffer. Tetramethylbenzidine substrate was added, and the plate was incubated in 254 
the dark for an additional 25 minutes at room temperature. Stop solution was added and the 255 
optical density was read at 450nm on a Infinite M200 Pro plate reader 1110. Samples were 256 
analysed in duplicate. The sensitivity was 0.007 µg/d, intra-assay coefficient of variation was 257 
5.74% and inter-assay coefficient of variation was 5.16%.  258 
 259 
2.6 Progesterone assays  260 
Twice weekly serum samples were collected from mares starting at ovulation immediately 261 
prior to oil infusion. Progesterone was determined by competitive immunoassay (Immulite 262 
Progesterone) and measured on an Immulite 1000 analyser at Rossdales Laboratories, as 263 
previously described [32].  264 
 265 
2.7 Statistical analysis 266 
Statistical analysis was performed in GraphPad Prism 611. Normality testing was performed 267 
on all data sets. Inter-ovulatory period was compared using a paired t-test. Differences in 268 
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salivary cortisol in experiment 1 were assessed using a repeat measures two-way ANOVA 269 
and post hoc Bonferroni’s multiple comparisons test with the source of variation defined as 270 
time and treatment and comparing all time points to sample 1 (‘Paddock’). Differences in 271 
salivary cortisol in experiment 2 were assessed using a Friedman test with a post hoc Dunn’s 272 
multiple comparison test.  A comparison of endometrial Kenny Grade and eosinophil counts 273 
before and after infusion of the oil was made using a Wilcoxon matched-pairs signed rank 274 
test.    275 
  276 
3. Results 277 
 278 
3.1 Efficacy of treatment 279 
There was no significant difference in interovulatory period when mares received a sham 280 
(n=6) or intrauterine peanut oil infusion infusion (n=6) (Supplementary Figure 1, P=0.8433). 281 
The mean +/- SE inter-ovulatory period for mares receiving sham treatment was 23+/- 2.1 282 
days and for oil treatment 28.2+/- 5.8 days.  In four mares, intrauterine oil infusion did not 283 
extend the interovulatory period beyond what would be expected under physiologically 284 
normal conditions (interovulatory periods of 14, 20; 21 and 22 days) (Fig. 1, Mares I-IV). 285 
Two mares that received intrauterine peanut infusion experienced prolonged interovulatory 286 
periods of 45 and 47 days (Fig. 1, Mares V, VI).  287 
 288 
3.2 Uterine response to treatment 289 
No intrauterine fluid was detected using ultrasonography in any of the mares during oestrus 290 
prior to pre-treatment control biopsies being taken, prior to sham treatment, or prior to oil 291 
treatment. One of six mares exhibited opaque vulval discharge twenty four hours after oil 292 
treatment, which was not obvious 48 hours after treatment. Ultrasonographic examination of 293 
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the reproductive tract 24 hours after oil infusion demonstrated a ‘delineating’ pattern in the 294 
uterine horns of all six mares (Fig 2A). In 4/6 mares, in whom oil treatment was not 295 
associated with a prolonged interovulatory period, hyperechoic free fluid of 0.5-3cm depth 296 
was imaged within the uterine lumen 24 hours after treatment (Fig. 2B). No treatment was 297 
given to clear this fluid. Endometrial swabs taken at the beginning of the next oestrus from 298 
3/4 of the mares who had free fluid in the uterus 24 hours after oil infusion, were found to be 299 
negative for pathogenic bacteria and fungal growth when cultured for 48 hours under aerobic 300 
and anaerobic conditions on 5% sheep blood agar, MacConkey agar, and 301 
Staphylococcus/Streptococcus selective agar, all at 37°C. The fourth mare (with a fluid depth 302 
of 0.5cm) was not swabbed, for the reasons related to licensing explained above. Culture of 303 
the peanut oil from the same batch used to infuse the mares was also negative for bacterial 304 
and fungal growth 305 
 306 
Endometrial biopsies (n=6 mares, one each from left and right horn) collected prior to peanut 307 
oil infusion showed no evidence of significant inflammatory or glandular disease. Following 308 
intrauterine oil infusion, endometrial biopsies were collected at the next return to oestrus. 309 
This ranged from 10 to 40 days following oil infusion. There was no significant difference in 310 
the endometrial Kenney Grade before and after intrauterine infusion of peanut oil (n=6, 311 
p=0.999) (Table II). There was no change in the endometrial Kenney Grade for biopsies from 312 
both left and right uterine horns before or after intrauterine peanut oil infusion in 4/6 mares 313 
(Table II). In 2/6 mares, the Kenney grade for one of the two biopsies collected from each 314 
mare post-treatment transiently worsened from grade I to grade IIa, returning to pre-oil 315 
classification by the second oestrus period post oil infusion (Table II). None of the mares 316 
biopsied post oil infusion showed significant endometrial inflammatory or glandular disease, 317 
consistent with the failure to culture pathogens from endometrial swabs. The four mares that 318 
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returned to oestrus rapidly after oil treatment all showed multifocal erosion of the surface 319 
epithelium, and in some cases this was associated with scattered subjacent or transmigrating 320 
neutrophils, consistent with surface or intraluminal irritation (Figure 3A-D). Two mares only 321 
showed small or rare surface erosion of the epithelium. As a direct result of the prolonged 322 
dioestrus experienced by these two mares, these biopsies were collected significantly longer 323 
after oil infusion (37, 40 days). The presence of eosinophils in endometrial biopsies was 324 
noted in 4/6 mares post peanut oil infusion but only 1/6 mares prior to infusion of the peanut 325 
oil (Fig. 4A). Eosinophil counts were quantified in endometrial sections pre and post peanut 326 
oil infusion. The median number of eosinophils in the endometrium was significantly 327 
increased post peanut oil infusion (p=0.0068) when compared to numbers prior to the oil 328 
infusion (Fig. 4B).   329 
 330 
3.3 Stress response to treatment 331 
In order to determine whether the infusion of peanut oil was painful, salivary cortisol was 332 
monitored prior and immediately following the intrauterine infusion of peanut oil or sham 333 
treatment. There was no significant difference in the salivary cortisol levels in mares 334 
receiving intrauterine peanut oil or sham treatment at any time point (Fig. 5A). There was a 335 
significant increase in salivary cortisol following placement of the mares into the stocks and a 336 
rectal examination (pre-treatment) when compared to salivary cortisol levels measured in the 337 
paddock for both sham and oil groups (Fig. 5A). This rise in salivary cortisol was sustained at 338 
10 minutes post oil/sham treatment but then dropped back to paddock levels for the 339 
remainder of the measurement period. To further explore whether the transient rise in salivary 340 
cortisol was due to restraint or rectal examination, a second cortisol experiment was 341 
performed whereby salivary cortisol was measured in the paddock, after placement in stocks 342 
(but with no rectal examination performed) then at 30, 60, 180 and 240 minutes after removal 343 
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from stocks, to mimic a selection of the sampling time in Fig 5A. There was no transient rise 344 
in salivary cortisol following placement in stocks alone (n=3 mares) (Fig 5B). There was a 345 
significant decrease in salivary cortisol at 180 minutes post removal from stocks.  346 
 347 
One mare who did not experience an extended interovulatory period following treatment 348 
exhibited behavioural signs of mild discomfort (elevated tail, vulval ‘winking’) from 10-30 349 
minutes following oil infusion. No behavioural signs of discomfort (elevated tail, vulval 350 
‘winking’) were observed in the remaining 5 mares following either the sham or peanut oil 351 
infusion.  352 
Discussion 353 
The primary purpose of this paper was to investigate the effects of intrauterine peanut oil - a 354 
treatment which had previously been reported to be an efficacious method of suppressing 355 
oestrus in mares - on endometrial health, and salivary cortisol levels. Intrauterine infusion of 356 
peanut oil caused some superficial erosion of the surface epithelium of the endometrium in all 357 
mares. This was most pronounced in mares who did not undergo a prolonged luteal phase, 358 
and thus were biopsied much later in relation to the day of treatment. Though the superficial 359 
nature of the damage makes it likely to repair spontaneously, the licensing constraints of this 360 
project meant that we do not know for certain that a repair process occurred, or how long it 361 
takes. Whilst it persists, the superficial erosion of the epithelium may compromise mares’ 362 
endometrial immune defence system, and make them more prone to endometrial infection 363 
caused, for example, by environmental contaminants which access the reproductive tract.  364 
 365 
Four of six mares also appeared to exhibit an immunological reaction to the peanut oil, as 366 
evidenced by ultrasonography, histology and bacteriology.  The ultrasonographic appearance 367 
of oil in the uterus immediately and in the days after infusion -  a ‘delineating’ pattern 368 
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believed to be caused by the hyperechoic oil lining the endometrial folds (which were 369 
themselves not pronounced because the mares were in dioestrus) -  was very similar in this 370 
study to that reported by Diel de Amorim et al [28]. The hyperechogenicity, distribution and 371 
volume of this pattern allowed it to be easily distinguished from non-oil, free fluid in the 372 
uterus. None of the mares who underwent a prolonged luteal phase following oil treatment in 373 
this study exhibited free intrauterine fluid on ultrasonography 24 hours after oil infusion. 374 
Conversely, all of the mares who did not undergo a prolonged luteal phase did exhibit 375 
intrauterine fluid following treatment. Ultrasonographically detected intrauterine fluid can be 376 
either infectious or sterile. Possible sources of infection include contamination with 377 
environmental pathogens during the catheterisation of the cervix, and bacterial contamination 378 
with the oil. Mares were prepared for catheterisation according to standard procedures which 379 
are practiced during successful embryo transfer by the authors. Guarded endometrial swabs 380 
taken from three of the mares who had free fluid in the uterus 24 hours after oil infusion were 381 
negative for pathogenic bacteria (the fourth mare was not swabbed). The fact that none of the 382 
mares underwent a short luteal phase on the sham cycle suggests that contamination due to 383 
poor technique was unlikely.  Bacteriological culture of the oil was negative. This is 384 
consistent with the findings of Diel de Amorim et al [28], who cultured their coconut oil to 385 
rule out infection as a cause of treated mares undergoing shortened luteal phases, and also got 386 
negative culture results 387 
 388 
Diel de Amorim et al [28] reported a lymphoplasmocytic inflammatory cell infiltration and 389 
neutrophilic inflammation of the stratum compactum of the endometrium following 390 
intrauterine coconut oil infusion, with occasional eosinophils seen.  The inflammatory 391 
response to intrauterine peanut oil infusion seen in this study was predominantly eosinophilic, 392 
with an increase in the number of eosinophils observed in the endometrium following 393 
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intrauterine peanut oil infusion. This is consistent with previous reports that eosinophils are 394 
found only occasionally in endometrial biopsies from clinical normal mares [33], but are 395 
frequently associated with an acute immune reaction (e.g. to seminal plasma [34]), and in 396 
cases of pneumovagina / pneumouterus [31] . Indeed, an acute immunological response to oil 397 
in the uterus has been described previously [35].  398 
 399 
Although negative culture results from the mares and the oil make it unlikely, we cannot 400 
definitively rule out infection, which subsequently resolved, as the cause of the fluid which 401 
was imaged in the uterus post treatment. Nonetheless, the combination of the 402 
ultrasonographical, biopsy and laboratory results in 4/6 mares who did not undergo a 403 
prolonged luteal phase in response to treatment are more suggestive of a transient, sterile, 404 
eosinophilic, hypersensitivity-like endometrial inflammation, reaction to the peanut oil, 405 
although to make this conclusion, this would need to be assessed immediately following 406 
treatment. Either way, this uterine inflammation presumably provokes a release of PGF2α 407 
from the endometrium, that out- competes any potential anti-luteolytic effects of the peanut 408 
oil fatty acids, leading to luteolysis.  409 
 410 
The clinical significance of this eosinophilic infiltrate in some mares following intrauterine 411 
infusion of peanut oil needs to be further investigated. We do not know whether repeated 412 
intrauterine infusions of peanut oil in such mares are likely to result in a gradual 413 
desensitisation to treatment, or, conversely, in an increased sensitisation, with an associated 414 
possible risk of a more systemic reaction. Previous research on intrauterine inflammatory 415 
reactions in the mare suggests that treatment with steroidal or non-steroidal anti-416 
inflammatory drugs [36, 37] at the time of intrauterine peanut oil infusion could dampen / 417 
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abolish the hypersensitivity-like, eosinophilic response, thereby increasing the likelihood of 418 
mares responding to treatment. However, this possibility is currently unproven and requires 419 
further research. Furthermore, any injection (however well tolerated) constitutes a welfare 420 
harm, and the ethical justification of inflicting that harm in order to improve the chances of 421 
an otherwise unsuccessful treatment working when  a non-painful, efficacious, licensed 422 
alternative treatment is available is doubtful.  423 
 424 
One of the aims of this study was to determine whether intrauterine infusion of peanut oil is 425 
painful for mares. This was assessed using a combination of observations of behavioural 426 
indicators of stress / pain and measurements of salivary cortisol as an indicator of stress [38, 427 
39]. The fact that one mare who did not undergo a prolonged interovulatory interval 428 
following treatment exhibited behavioural signs of mild discomfort (elevated tail, vulval 429 
‘winking’) from 10-30 minutes after oil infusion should not be ignored. However, in 5/6 430 
mares the oil treatment appeared to be well-tolerated, with no behavioural indicators of stress 431 
/ pain (for example kicking/stomping feet, listlessness, reluctance to eat, abnormal facial 432 
expressions) being observed. Furthermore, the cortisol results show that there was no stress 433 
response associated with intrauterine infusion of oil itself. However, there was a stress 434 
response associated with the rectal examination which was performed prior to oil infusion, as 435 
confirmed by the additional experiment undertaken to differentiate between the effects of 436 
restraint in stocks and rectal examination on stress. This is consistent with a finding recently 437 
reported by others [39] for lactating and non-lactating pregnant mares, and, to the authors’ 438 
knowledge, is the first demonstration of a stress response to rectal examination in non-439 
pregnant mares. 440 
 441 
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This study took as its starting point the fact that intrauterine infusion of peanut oil had been 442 
previously shown to be an effective method of oestrus suppression in mares. Our primary 443 
aims were to assess the effects of that treatment on endometrial health and salivary cortisol. It 444 
is noteworthy, however, that the efficacy of intrauterine peanut oil at prolonging dioestrus 445 
was significantly lower in this experiment than in the one previous report [24]. In that study, 446 
luteal persistence for 30 days was reported in 11/12 mares following treatment. In the present 447 
study, intrauterine oil infusion was associated with increased interovulatory periods (of 45 448 
and 47 days) in 2/6 mares, however when taking into account the 4/6 mares that did not 449 
respond to treatment, this observation was not statistically significant. Such variability of 450 
responses between mares has also been reported for other methods of oestrus suppression 451 
(e.g. [4, 15, 18, 19]). It is also consistent with the recent work of Diel de Amorim et al [28], 452 
which failed to reproduce the results which Wilsher and Allen [24] obtained with coconut oil. 453 
Furthermore, since mares are known to undergo spontaneously prolonged luteal phases [40, 454 
41], it is possible that the prolonged interovulatory period in 2/6 mares was not actually 455 
caused by the oil treatment.    456 
 457 
The variability between our results and those of Wilsher and Allen [24] could potentially be 458 
explained by a difference in the exact composition of the peanut oil used in the two studies. 459 
All experiments described in this paper used a standardised batch of peanut oil (Arachis Oil 460 
BP20085), which was batch tested for fatty acid composition (Table I), in order to enable 461 
regulatory bodies to assess its permissibility. It is impossible to accurately compare the 462 
composition of this batch with that of the peanut oil used by Wilsher and Allen [24] because, 463 
although those authors provided a table of the general composition of peanut oil, the paper 464 
did not describe the exact composition of the batch which they used.  Nonetheless, when one 465 
compares the generic composition provided by Wilsher and Allen [24] and the composition 466 
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of the peanut oil which we used, there do not seem to be differences sufficient to account for 467 
a disparity in response. For example, it would be unlikely that the slightly higher levels of 468 
oleic acid in the batch used in this study (69.8% versus range 36.4-67.1%) would lead to 469 
more rapid luteolysis. Previous studies have shown that if one exposes pregnant ewe 470 
endometrial cells to increasing concentrations of oleic acid, the ratio of PGF2α:PGE2 moves 471 
in favour of PGE2 [42]. If one applies this concept to the non-pregnant mare endometrium, 472 
the oil used in this study, if anything, should have lengthened the period to luetolysis. 473 
 474 
Another possible reason that mares might have failed to enter prolonged dioestrus following 475 
treatment would be if the process of infusion itself caused luteolysis, via a prostaglandin 476 
release provoked by cervical stimulation [29]. Wilsher and Allen [24] used Wilsher forceps 477 
[43] to facilitate oil infusion.  In the present study, a conventional, commonly-used non-478 
surgical embryo transfer technique [29] was used to pass the pipette through the cervix, as 479 
this technique is what would more likely be used by clinicians in general practice.  The 480 
technique used in this study was also used in the study on intrauterine coconut oil by Diel de 481 
Amorim et al [28]. It is unlikely that the difference in technique for cervical catheterisation 482 
between this study and that of Wilsher and Allen [24] resulted in a prostaglandin release 483 
which would account for the failure of luteostasis in 4/6 mares. The operator has years of 484 
successful experience with non-surgical embryo transfer using the technique adopted in this 485 
study. More importantly, if luteolysis was being caused by insertion of the pipette through the 486 
cervix, one would have expected that to occur during the sham treatment as well oil 487 
treatment, whereas in fact no shortening of the inter-ovulatory period following sham 488 
treatment was recorded. 489 
 490 
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In addition to the clinical information provided by this study, those contemplating using 491 
intrauterine peanut oil to suppress oestrus in mares should be aware of the legislative and 492 
regulatory implications. Intrauterine peanut oil is likely to be classified as a medicine by 493 
medicines regulatory authorities. It is currently unlicensed for oestrus suppression, whereas 494 
licensed products (e.g. Altrenogest, Regumate Equine1 and Readyserv2) are available. 495 
Furthermore, peanut oil might also be considered to be a medicine by sport regulatory 496 
authorities. In that case, its use might be prohibited during competition, though its use prior to 497 
the competition period (meaning that mares were still in dioestrus at the time of competition) 498 
might be permitted – this needs regulatory clarification. 499 
 500 
Conclusions 501 
The results of this study suggest that, like intrauterine infusion of coconut oil [27] intrauterine 502 
infusion of peanut oil is at least temporarily detrimental to endometrial health. Veterinarians 503 
recommending the use of intrauterine peanut oil infusion should be aware that neither this 504 
study nor the papers published by Wilsher and Allen [24] and Diel de Amorim et al [28] 505 
included any assessment of pregnancy rates in mares bred when they returned to oestrus after 506 
oil treatment. Until this data is made available by future research, the long-term implications 507 
of intrauterine peanut oil infusion for fertility are unproven. Furthermore, similar to recent 508 
work using intrauterine treatment with coconut oil [28], this study failed to demonstrate that 509 
intrauterine peanut oil is an efficacious method of oestrus suppression.  510 
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SUMMARY OF FIGURES AND TABLES: 2 tables and 5 figures 650 
 651 
FIGURE LEGENDS 652 
 653 
Table I: Composition of Peanut Oil (Arachis Oil BP2008, batch PE108505), measured by 654 
gas liquid chromatography. SFA indicates saturated fatty acid, MUFA indicates 655 
monounsaturated fatty acid, PUFA indicates poly-unsaturated fatty acid. 656 
 657 
Table II: Endometrial histological features prior to and following infusion of peanut oil. 658 
Results for the left horn and right horn are shown as l/r.  * indicates a valid biopsy was not 659 
read.  aBiopsies taken at an oestrus prior to infusion of peanut oil. b,dBiopsies taken at first 660 
oestrus following infusion of peanut oil. cBiopsies taken at second oestrus following infusion 661 
of peanut oil.  662 
 663 
Figure 1: Serum progesterone in mares I-VI (Table II) administered 1 ml intrauterine peanut 664 
oil on day 10 post ovulation (indicated by *). Day 0 is the day of ovulation immediately prior 665 
to administration of the oil.  666 
 667 
 Figure 2: Ultrasound images taken 24 hours after the intrauterine infusion of peanut oil. The 668 
image on the left was taken from a mare, who underwent a prolonged interovulatory period 669 
following intrauterine peanut oil infusion. This shows oil (hyperechoic) delineating the 670 
dioestrus endometrial folds of the right uterine horn as it spreads and is trapped between 671 
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them. The image on the right is taken from a mare, who returned to oestrus within 4 days 672 
following treatment. Note the measurable quantity (>2cm) of hyperechoic fluid within the 673 
lumen of the uterine horn, which is believed to represent a sterile inflammatory reaction to 674 
the oil infusion. 675 
 676 
Figure 3: Endometrial biopsies pre- and post-oil administration. H and E stained 677 
representative sections in mares that had short (top (Mare I) and middle (Mare II)) and long 678 
(bottom panel (Mare VI)) inter-ovulatory periods following oil infusion. Top panel pre-oil: 679 
intact endometrial surface epithelium with scattered stromal leucocytes; post-oil: endometrial 680 
surface erosion with small to moderate numbers of stromal leucocytes. Middle panel pre-oil: 681 
intact endometrial surface epithelium with small numbers of stromal leucocytes; post-oil: 682 
endometrial surface erosion with small to moderate numbers of stromal leucocytes. Bottom 683 
panel pre-oil: intact endometrial surface epithelium with scattered stromal leucocytes; post-684 
oil: intact endometrial surface epithelium with scattered stromal leucocytes. 685 
  686 
Figure 4 (A). Endometrial biopsy showing eosinophilic infiltration of superficial stroma with 687 
associated oedema.  Eosinophil arrowed.  H&E x400. (B). Eosinophil numbers in the 688 
endometrium prior to and following the administration of intrauterine peanut oil (n=11 689 
sections, line indicates median value).   690 
Figure 5: Figure 5 (A). Salivary cortisol measured prior to and following the administration 691 
of 1 ml intrauterine peanut oil (n=6) or sham (n=6) procedure. Saliva samples were taken in 692 
the paddock prior to moving the mares into the stocks (paddock), after restraint in stocks, 693 
rectal examination and preparation of the vulvar region and immediately prior to 694 
administration of sham or peanut oil (pre-tx), and 10-240 minutes following the 695 
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administration of oil (black bars) or sham delivery (grey bars). B. Salivary cortisol was 696 
measured in a paddock, after restraint in the stocks (pre-tx) and at 30-240 minutes following 697 
removal from the stocks (n=3 mares). Cortisol was measured using an enzyme immunoassay 698 
as described in materials and methods. * indicates p<0.05 and *** p<0.001 compared to the 699 
paddock sample.  700 
 701 
 702 
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Table II Endometrial histological features prior to and following infusion of peanut oil. Results for the 
left horn and right horn are shown as l/r. The * indicates a valid biopsy was not read.  
a
Biopsies taken 
at an oestrus prior to infusion of peanut oil. 
b
Biopsies taken at first oestrus following infusion of 
peanut oil. 
c
Biopsies taken at second oestrus following infusion of peanut oil. 
d
Biopsies taken at first 
oestrus post infusion of intrauterine peanut oil. 
 
 Kenny Grade Erosion of 
surface 
epithelium
d
 
Eosinophil 
Count Pre oil 
Infusion LH/RH 
Eosinophil 
Count Post oil 
Infusion LH/RH Pre-Oil
a
 Post-Oil 1
b
 Post-Oil 2
c
 
Normal interovulatory period 
Mare I  I/IIa IIa/IIa I/I Multifocal 1/0 0/1 
Mare II  IIa/IIa IIa/IIa n/a Multifocal 2/3 20/30 
Mare III  I/I IIa/I I/I Multifocal 0/0 24/16 
Mare IV  I/* I/I n/a Multifocal 2/* 6/0 
Prolonged interovulatory period 
Mare VI  I/IIa I/I n/a Small 10/16 12/20 
Mare VI  I/I I/I n/a Rare 0/1 2/0 
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Table I: Composition of Peanut Oil (Arachis Oil BP2008, batch PE108505) as measured by gas liquid 
chromatography. SFA indicates saturated fatty acid, MUFA indicates monounsaturated fatty acid, 
PUFA indicates poly-unsaturated fatty acid. 
Fatty Acid Classification Systematic Name Total fatty 
acids (%) 
Palmitic Acid SFA Hexadecanoic acid 6.24 
Stearic acid SFA Octadecanoic acid 1.77 
Oleic acid MUFA Omega-9 9-Octadecenoic acid 69.77 
Linoleic acid PUFA Omega-6 9,12-Octadecadienoic acid 12.26 
Linolenic acid PUFA Omega-3 9,12,15-Octadecatrienoic acid 0.22 
Arachidic acid SFA Eicosanoic acid 0.92 
Eicosenoic acid MUFA (z)-icosa-11-enoic acid 2.86 
Behenic acid SFA Docosanoic acid 2.75 
Erucic acid MUFA Omega-9 cis-13-docosenoic acid 0.45 
Lignoceric acid SFA Tetracosanoic acid 2.05 
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Highlights:  
 
Campbell et al, The effects of intrauterine infusion of peanut oil on endometrial health, 
salivary cortisol, and interovulatory period in mares 
 
• The response to intrauterine infusion of peanut oil in dioestrus mares is variable 
• Intrauterine peanut oil does not statistically prolong the luteal phase in mares 
• Intrauterine peanut oil causes superficial erosion of endometrial surface epithelium 
• Intrauterine peanut oil causes an increase in endometrial eosinophil numbers 
• Rectal examination but not intrauterine peanut oil causes a rise in salivary cortisol 
 
